Adipocyte NCoR Knockout Decreases PPARγ Phosphorylation and Enhances PPARγ Activity and Insulin Sensitivity: Cell
Measuring biomarkers to assess the therapeutic effects of PPAR agonists? | Pharmacogenomics
Cureus | Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions | Article
PIOGLITAZONE - Pharmacology - YouTube
Frontiers | PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
PPAR Agonists and Cardiovascular Disease in Diabetes
Mechanism by which of PPAR γ ligands regulate insulin sensitivity. In... | Download Scientific Diagram
PPARγ signaling and metabolism: the good, the bad and the future | Nature Medicine
Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs | Scientific Reports
IJMS | Free Full-Text | Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
Endocrinologic and Metabolic Drugs Peroxisome Proliferator-Activated Receptor (PPAR) Agonists Preclinical and Clinical Cardiac Safety Considerations Jeri. - ppt download
Peroxisome proliferator-activated receptor γ in diabetes and metabolism - ScienceDirect
PPAR Agonists: Definition and Overview -Diabetes Self-Management
JCI Insight - Dual PPARα/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction
PPAR Inhibition | PPAR Agonist Review
PPAR agonist - Wikipedia
IJMS | Free Full-Text | The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? | International Journal of Obesity
Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo: Cell
PDB-101: Global Health: Diabetes Mellitus: Drugs: Thiazolidinedione: PPAR-γ
IJMS | Free Full-Text | PPAR Agonists and Metabolic Syndrome: An Established Role?
effects of dual PPAR alpha and gamma agonists in ADD | Download Table
Molecules | Free Full-Text | Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
![PDF] A clinical update on peroxisome proliferator-activated receptors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8d9fd09e39613346f83fc51709f77ecd8d56c850/2-Table1-1.png "PDF] A clinical update on peroxisome proliferator-activated receptors | Semantic Scholar")